Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 USD | -7.51% | -10.75% | -87.87% |
02:00pm | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
01:12pm | Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 102M | Sales 2025 * | 167K | Capitalization | 131M |
---|---|---|---|---|---|
Net income 2024 * | -105M | Net income 2025 * | -84M | EV / Sales 2024 * | 0.78 x |
Net cash position 2024 * | 51.6M | Net cash position 2025 * | 168M | EV / Sales 2025 * | -222 x |
P/E ratio 2024 * |
-1.26
x | P/E ratio 2025 * |
-1.63
x | Employees | 384 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.02% |
Latest transcript on Amylyx Pharmaceuticals, Inc.
1 day | -7.51% | ||
1 week | -10.75% | ||
Current month | -1.38% | ||
1 month | -33.15% | ||
3 months | -88.94% | ||
6 months | -85.44% | ||
Current year | -87.87% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 12-12-31 |
Josh Cohen
FOU | Founder | 33 | 12-12-31 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 14-12-31 |
Kari Firestone
BRD | Director/Board Member | - | 23-03-15 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 21-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | +2.81% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 0 M€ | +8.58% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.785 | -7.51% | 2 300 131 |
24-05-08 | 1.93 | -2.03% | 1,514,637 |
24-05-07 | 1.97 | -1.01% | 900,905 |
24-05-06 | 1.99 | -1.97% | 1,527,305 |
24-05-03 | 2.03 | +1.50% | 1,478,023 |
Delayed Quote Nasdaq, May 09, 2024 at 12:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.87% | 131M | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.59% | 31.99B | |
+50.51% | 24.73B | |
-15.13% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-15.38% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- AMLX Stock